Wai Yuen Tong Medicine Holdings Limited released its resubmitted Monthly Return for the period ended 31 March 2026, confirming a stable capital structure and compliance with public-float requirements on the Hong Kong Stock Exchange.

• Authorised Share Capital The company’s authorised share capital remained unchanged at 60.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 600.00 million.

• Issued Share Capital and Treasury Shares Issued shares stood at 1.13 billion, identical to the prior month’s level, and no treasury shares were held at month-end. No new shares were issued or cancelled during March.

• Share Repurchase Pending Cancellation The filing notes a previously executed repurchase of 10.72 million ordinary shares on 19 August 2025 that are earmarked for cancellation but had not yet been cancelled as of 31 March 2026.

• Public-Float Compliance Wai Yuen Tong affirmed that it satisfied the Main Board’s minimum public-float threshold of 25% of issued shares as at the end of March 2026.

• Absence of Dilutive Instruments The company reported no outstanding share options, warrants, convertible securities, or other agreements that could lead to future share issuance.

The disclosure, signed by Company Secretary Ng Yee Man, confirms that all regulatory and listing-rule obligations tied to the month’s movements—or lack thereof—have been duly met.